191 related articles for article (PubMed ID: 12463751)
1. Glycosylation of erythropoietin affects receptor binding kinetics: role of electrostatic interactions.
Darling RJ; Kuchibhotla U; Glaesner W; Micanovic R; Witcher DR; Beals JM
Biochemistry; 2002 Dec; 41(49):14524-31. PubMed ID: 12463751
[TBL] [Abstract][Full Text] [Related]
2. The influence of artificially introduced N-glycosylation sites on the in vitro activity of Xenopus laevis erythropoietin.
Nagasawa K; Meguro M; Sato K; Tanizaki Y; Nogawa-Kosaka N; Kato T
PLoS One; 2015; 10(4):e0124676. PubMed ID: 25898205
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin and co.: intrinsic structure and functional disorder.
Uversky VN; Redwan EM
Mol Biosyst; 2016 Dec; 13(1):56-72. PubMed ID: 27833947
[TBL] [Abstract][Full Text] [Related]
4. Changes in conformation and stability upon formation of complexes of erythropoietin (EPO) and soluble EPO receptor.
Narhi LO; Aoki KH; Philo JS; Arakawa T
J Protein Chem; 1997 Apr; 16(3):213-25. PubMed ID: 9155092
[TBL] [Abstract][Full Text] [Related]
5. Post-secretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle.
Maruyama H; Higuchi M; Higuchi N; Kameda S; Saito M; Sugawa M; Matsuzaki J; Neichi T; Yokoyama S; Miyazaki Y; Miyazaki J; Gejyo F
J Gene Med; 2004 Feb; 6(2):228-37. PubMed ID: 14978776
[TBL] [Abstract][Full Text] [Related]
6. N-glycosylation-defective receptor for erythropoietin can transduce the ligand-induced cell proliferation signal.
Nagao M; Morishita E; Hanai Y; Kobayashi K; Sasaki R
FEBS Lett; 1995 Oct; 373(3):225-8. PubMed ID: 7589471
[TBL] [Abstract][Full Text] [Related]
7. Effects of ammonia and glucosamine on the heterogeneity of erythropoietin glycoforms.
Yang M; Butler M
Biotechnol Prog; 2002; 18(1):129-38. PubMed ID: 11822911
[TBL] [Abstract][Full Text] [Related]
8. Identification of a critical ligand binding determinant of the human erythropoietin receptor. Evidence for common ligand binding motifs in the cytokine receptor family.
Middleton SA; Johnson DL; Jin R; McMahon FJ; Collins A; Tullai J; Gruninger RH; Jolliffe LK; Mulcahy LS
J Biol Chem; 1996 Jun; 271(24):14045-54. PubMed ID: 8662939
[TBL] [Abstract][Full Text] [Related]
9. Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP).
Gross AW; Lodish HF
J Biol Chem; 2006 Jan; 281(4):2024-32. PubMed ID: 16286456
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the Asymmetry of Activated EPO Receptor Enables Designing Small Molecule Agonists.
Guarnieri F
Vitam Horm; 2017; 105():19-37. PubMed ID: 28629518
[TBL] [Abstract][Full Text] [Related]
11. The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin.
Wasley LC; Timony G; Murtha P; Stoudemire J; Dorner AJ; Caro J; Krieger M; Kaufman RJ
Blood; 1991 Jun; 77(12):2624-32. PubMed ID: 2043765
[TBL] [Abstract][Full Text] [Related]
12. Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide.
Middleton SA; Barbone FP; Johnson DL; Thurmond RL; You Y; McMahon FJ; Jin R; Livnah O; Tullai J; Farrell FX; Goldsmith MA; Wilson IA; Jolliffe LK
J Biol Chem; 1999 May; 274(20):14163-9. PubMed ID: 10318834
[TBL] [Abstract][Full Text] [Related]
13. Asn to Lys mutations at three sites which are N-glycosylated in the mammalian protein decrease the aggregation of Escherichia coli-derived erythropoietin.
Narhi LO; Arakawa T; Aoki K; Wen J; Elliott S; Boone T; Cheetham J
Protein Eng; 2001 Feb; 14(2):135-40. PubMed ID: 11297671
[TBL] [Abstract][Full Text] [Related]
14. Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: implications for soluble receptor function.
Schimmenti LA; Blechert G; Harris KW; Winkelmann JC
Exp Hematol; 1995 Dec; 23(13):1341-6. PubMed ID: 7498361
[TBL] [Abstract][Full Text] [Related]
15. The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation.
Sawyer ST; Hankins WD
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6849-53. PubMed ID: 8341708
[TBL] [Abstract][Full Text] [Related]
16. Characterization of intact glycopeptides reveals the impact of culture media on site-specific glycosylation of EPO-Fc fusion protein generated by CHO-GS cells.
Wang Q; Yang G; Wang T; Yang W; Betenbaugh MJ; Zhang H
Biotechnol Bioeng; 2019 Sep; 116(9):2303-2315. PubMed ID: 31062865
[TBL] [Abstract][Full Text] [Related]
17. Highly sialylated recombinant human erythropoietin production in large-scale perfusion bioreactor utilizing CHO-gmt4 (JW152) with restored GnT I function.
Goh JS; Liu Y; Liu H; Chan KF; Wan C; Teo G; Zhou X; Xie F; Zhang P; Zhang Y; Song Z
Biotechnol J; 2014 Jan; 9(1):100-9. PubMed ID: 24166780
[TBL] [Abstract][Full Text] [Related]
18. Quick preparation of nanoluciferase-based tracers for novel bioluminescent receptor-binding assays of protein hormones: Using erythropoietin as a model.
Song G; Wu QP; Xu T; Liu YL; Xu ZG; Zhang SF; Guo ZY
J Photochem Photobiol B; 2015 Dec; 153():311-6. PubMed ID: 26506452
[TBL] [Abstract][Full Text] [Related]
19. Sialic acid-specific affinity chromatography for the separation of erythropoietin glycoforms using serotonin as a ligand.
Meininger M; Stepath M; Hennig R; Cajic S; Rapp E; Rotering H; Wolff MW; Reichl U
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1012-1013():193-203. PubMed ID: 26851523
[TBL] [Abstract][Full Text] [Related]
20. Engineering a soluble extracellular erythropoietin receptor (EPObp) in Pichia pastoris to eliminate microheterogeneity, and its complex with erythropoietin.
Zhan H; Liu B; Reid SW; Aoki KH; Li C; Syed RS; Karkaria C; Koe G; Sitney K; Hayenga K; Mistry F; Savel L; Dreyer M; Katz BA; Schreurs J; Matthews DJ; Cheetham JC; Egrie J; Giebel LB; Stroud RM
Protein Eng; 1999 Jun; 12(6):505-13. PubMed ID: 10388848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
